Drug Information

Drug General Information
Drug ID
D0H0LP
Former ID
DIB019550
Drug Name
compound 5g
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530930]
Structure
Download
2D MOL
Formula
C24H26Cl2N6
InChI
InChI=1S/C24H26Cl2N6/c1-30-8-10-31(11-9-30)23-5-2-17(14-28-23)18-13-22-24(29-15-18)27-6-7-32(22)16-19-12-20(25)3-4-21(19)26/h2-5,12-15H,6-11,16H2,1H3,(H,27,29)
InChIKey
CSYSNPSPLOLFFI-UHFFFAOYSA-N
PubChem Compound ID
46906624
PubChem Substance ID
103763834, 104142574, 137883242, 180416487, 224159619, 227795974, 249370917, 249565887
Target and Pathway
Target(s) doublecortin-like kinase 1 Target Info Inhibitor [530930]
ALK tyrosine kinase receptor Target Info Inhibitor [530930]
KEGG Pathway Non-small cell lung cancer
WikiPathways Differentiation Pathway
References
Ref 530930Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase. Bioorg Med Chem. 2010 Jun 15;18(12):4351-62.
Ref 530930Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase. Bioorg Med Chem. 2010 Jun 15;18(12):4351-62.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.